Drug intelligence / Profile preview

nestin siRNA

Development stage
Preclinical
Lead developer
Nippon Medical School
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

Nestin siRNA is a small interfering RNA therapeutic designed to target and silence the expression of nestin, a class VI intermediate filament protein. Nestin is a marker for progenitor/stem cells in the central nervous system and is highly expressed in various cancers, including pancreatic cancer, glioblastoma, and melanoma, where it correlates with tumor aggressiveness and metastasis. By silencing nestin mRNA, this siRNA inhibits cancer cell growth, migration, invasion, and sphere-forming ability. Preclinical studies in pancreatic cancer models have demonstrated that nestin siRNA, delivered via lipid nanoparticles (e.g., Invivofectamine), significantly reduces primary tumor growth and suppresses metastatic nodules in the liver and lungs, particularly when used in combination with gemcitabine.

Other names
siRNA targeting nestin
02

Targets

NES (Nestin)

Beyond the preview

Go deeper on nestin siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nestin siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call